keywords: Health policy,Pharmaceutical policy,Pharmaceuticals,Intellectual property,Patent
description:    Lim, David <https://eprints.qut.edu.au/view/person/Lim,_David.html>, Hepworth, Julie <https://eprints.qut.edu.au/view/person/Hepworth,_Julie.html>, Siegel, Evan, van Driel, Mieke,  & Nissen, Lisa <https://eprints.qut.edu.au/view/person/Nissen,_Lisa.html>   (2013)   Interferon-free therapy for hepatitis C, how prepared is Australia for biosimilars? In  Emerging Health Policy Research Conference, 14 October 2013, Darlington Centre, University of Sydney, Australia. (In Press)   
DC.date.modified: 2017-07-11